NCT00436449View on ClinicalTrials.gov

RN1001(Avotermin) in Scar Improvement Following Breast Augmentation

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

January 31, 2008

Conditions
MammaplastyCicatrix
Interventions
DRUG

Avotermin

Trial Locations (7)

BT9 6AF

The Fitzwilliam Clinic, Belfast

CH4 7QP

The Grosvenor Nuffield Hospital, Chester

HU10 7AZ

Classic Hull & East Riding, Hull

HU16 5FQ

Hull Nuffield Hospital, Hull

M13 9XX

Renovo CTU, Manchester

M16 8AJ

BUPA Hospital, Manchester

WA4 4LU

BUPA North Cheshire Hospital, Warrington

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00436449 - RN1001(Avotermin) in Scar Improvement Following Breast Augmentation | Biotech Hunter | Biotech Hunter